PONTE VEDRA, Fla., Dec. 11, 2025 -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome the limitations of current anticoagulation therapy, today announced the acquisition...
Borah
Borah was formed in 2022 when the company Boragen was split into three separate companies, 5Metis, Borah and Reactive Biosciences.
